| Pharmaceutical active ingredients: |
| Clorazepate Dipotassium |
| Available forms, composition and doses of Tranxen: |
| Capsules; Oral; Clorazepate Dipotassium 10 mgCapsules; Oral; Clorazepate Dipotassium 15 mgCapsules; Oral; Clorazepate Dipotassium 20 mgCapsules; Oral; Clorazepate Dipotassium 3.75 mgCapsules; Oral; Clorazepate Dipotassium 5 mgCapsules; Oral; Clorazepate Dipotassium 7.5 mgInjectable; Injection; Clorazepate Dipotassium 10 mg / mlInjectable; Injection; Clorazepate Dipotassium 20 mg / mlTablets; Oral; Clorazepate Dipotassium 11.25 mgTablets; Oral; Clorazepate Dipotassium 15 mgTablets; Oral; Clorazepate Dipotassium 22.5 mgTablets; Oral; Clorazepate Dipotassium 3.75 mgTablets; Oral; Clorazepate Dipotassium 7.5 mg |
| Tranxen medical category: |
| Human:Benzodiazepines |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05BA05 - Potassium Clorazepate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisPfizer |
| Related documents and information about Tranxen: |
| Tranxene T-Tab prescribing information (PDF) |